Literature DB >> 9346571

Transjugular intrahepatic portosystemic shunts: impact on liver transplantation.

J M Millis1, P Martin, A Gomes, A Shaked, S D Colquhoun, O Jurim, L Goldstein, R W Busuttil.   

Abstract

This study was designed to evaluate the impact of transjugular intrahepatic portosystemic shunts (TIPS) on liver transplantation. Historically, the complications of portal hypertension have been temporized with sclerotherapy or surgical portosystemic shunts. In patients whose liver disease progressed, liver transplantation has been used as definitive treatment. More recently, TIPS is being used increasingly for the management of the complications of portal hypertension. The impact of this new modality on liver transplantation is evaluated. The records of 135 adult patients undergoing liver transplantation at University of California at Los Angeles between October 1992 and June 1993 were reviewed. Twenty-three patients had received at least one shunt before transplantation. The TIPS procedure complicated the operative course of 5 patients (22%). In 2 patients the TIPS had been placed cephalad, making placement of the suprahepatic vena caval clamp difficult. In 2 other patients, the shunt had been placed caudad, extending in the extrahepatic portal vein. In all 4 of these patients, the intima had been damaged at the area of the subsequent anastomosis. In the fifth patient, the bile duct had been perforated during the placement of the shunt, causing diffuse bile peritonitis, which was sterile, and the transplantation was performed. The average intraoperative blood loss for these 5 patients was 13 U. There was no significant decrease in intraoperative blood loss for all patients with a TIPS when compared with 112 adults who underwent liver transplantation during the same period (11 U v 10.5 U). The TIPS stent did not improve objective intraoperative parameters as compared with liver transplant recipients without TIPS. The indications for TIPS must be carefully weighed against the potential risks of increasing the technical difficulty of the transplantation and jeopardizing the candidacy of some liver transplantation candidates. Liver transplantation is not facilitated by TIPS insertion and therefore should not be used to justify TIPS placement.

Entities:  

Mesh:

Year:  1995        PMID: 9346571     DOI: 10.1002/lt.500010406

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  7 in total

Review 1.  Transjugular Intrahepatic Portosystemic Shunt before and after Liver Transplantation.

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

2.  Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis.

Authors:  Harjit K Bhogal; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2011-06-21       Impact factor: 11.382

Review 3.  Liver transplantation in patients with liver cirrhosis and esophageal bleeding.

Authors:  Christian Hillert; Lutz Fischer; Dieter C Broering; Xavier Rogiers
Journal:  Langenbecks Arch Surg       Date:  2003-05-20       Impact factor: 3.445

4.  Impact of transjugular intrahepatic porto-systemic shunt on post liver transplantation outcomes: Study based on the United Network for Organ Sharing database.

Authors:  Khalid Mumtaz; Sherif Metwally; Rohan M Modi; Nishi Patel; Dmitry Tumin; Anthony J Michaels; James Hanje; Ashraf El-Hinnawi; Don Hayes; Sylvester M Black
Journal:  World J Hepatol       Date:  2017-01-18

Review 5.  Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View.

Authors:  Martin Rössle; Birke Bausch; Christoph Klinger
Journal:  Viszeralmedizin       Date:  2014-12

Review 6.  Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.

Authors:  Aikaterini Mantaka; Aikaterini Augoustaki; Elias A Kouroumalis; Dimitrios N Samonakis
Journal:  Ann Gastroenterol       Date:  2018-03-03

Review 7.  North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.

Authors:  Justin R Boike; Bartley G Thornburg; Sumeet K Asrani; Michael B Fallon; Brett E Fortune; Manhal J Izzy; Elizabeth C Verna; Juan G Abraldes; Andrew S Allegretti; Jasmohan S Bajaj; Scott W Biggins; Michael D Darcy; Maryjane A Farr; Khashayar Farsad; Guadalupe Garcia-Tsao; Shelley A Hall; Caroline C Jadlowiec; Michael J Krowka; Jeanne Laberge; Edward W Lee; David C Mulligan; Mitra K Nadim; Patrick G Northup; Riad Salem; Joseph J Shatzel; Cathryn J Shaw; Douglas A Simonetto; Jonathan Susman; K Pallav Kolli; Lisa B VanWagner
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-15       Impact factor: 13.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.